ASX - By Stock
|
MEI |
Re:
Ann: Successful Capital Raising to Fund Ongoing Development
|
|
Rippy66
|
62 |
31K |
1 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
62
|
31K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
AlphaSwiss
|
|
Rippy66
|
38 |
9.0K |
1 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
38
|
9.0K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
AlphaSwiss
|
|
Rippy66
|
38 |
9.0K |
0 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
38
|
9.0K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
AlphaSwiss
|
|
Rippy66
|
38 |
9.0K |
0 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
38
|
9.0K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: NSB to investigate treatment for post-COVID Fibrosis
|
|
Rippy66
|
43 |
9.4K |
4 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
43
|
9.4K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
0 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
1.5K
|
469K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Strategic Placement to AlphaSwiss Partners
|
|
Rippy66
|
16 |
3.7K |
2 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
16
|
3.7K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
29 |
6.1K |
0 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
29
|
6.1K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
29 |
6.1K |
1 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
29
|
6.1K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
29 |
6.1K |
0 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
29
|
6.1K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
29 |
6.1K |
0 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
29
|
6.1K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
29 |
6.1K |
0 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
29
|
6.1K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Rippy66
|
51 |
9.4K |
0 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
51
|
9.4K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Rippy66
|
51 |
9.4K |
0 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
51
|
9.4K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Rippy66
|
51 |
9.4K |
5 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
51
|
9.4K
|
5
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Rippy66
|
51 |
9.4K |
1 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
51
|
9.4K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Rippy66
|
51 |
9.4K |
1 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
51
|
9.4K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
1 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
1.5K
|
469K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
0 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
1.5K
|
469K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
1 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
1.5K
|
469K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
3 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
1.5K
|
469K
|
3
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
1 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
1.5K
|
469K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
1 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
1.5K
|
469K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Rippy66
|
1.5K |
469K |
3 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
1.5K
|
469K
|
3
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Updated Appendix 4C
|
|
Rippy66
|
13 |
2.9K |
4 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
13
|
2.9K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
Ann: EmtinB Positive Results in MS
|
|
Rippy66
|
105 |
20K |
4 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
105
|
20K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
billion dollar company in the making
|
|
Rippy66
|
77 |
18K |
1 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
77
|
18K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
billion dollar company in the making
|
|
Rippy66
|
77 |
18K |
0 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
77
|
18K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
billion dollar company in the making
|
|
Rippy66
|
77 |
18K |
2 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
77
|
18K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
billion dollar company in the making
|
|
Rippy66
|
77 |
18K |
3 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
77
|
18K
|
3
|
|
ASX - Day Trading
|
|
Re:
Morning trading July 15
|
|
Rippy66
|
465 |
80K |
4 |
15/07/20 |
15/07/20 |
ASX - Day Trading
|
465
|
80K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
Glaucoma,MS,and Alzeimer super drug of the future
|
|
Rippy66
|
96 |
19K |
2 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
96
|
19K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Ann: EmtinB Positive Results in MS
|
|
Rippy66
|
105 |
20K |
2 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
105
|
20K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Glaucoma,MS,and Alzeimer super drug of the future
|
|
Rippy66
|
96 |
19K |
0 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
96
|
19K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Positive Results in MS Study
|
|
Rippy66
|
81 |
19K |
1 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
81
|
19K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
24 |
5.3K |
2 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
24
|
5.3K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Positive Results in Glaucoma Pig Model
|
|
Rippy66
|
57 |
13K |
3 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
57
|
13K
|
3
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Positive Results in Glaucoma Pig Model
|
|
Rippy66
|
57 |
13K |
3 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
57
|
13K
|
3
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Rippy66
|
41 |
9.2K |
7 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
41
|
9.2K
|
7
|
|
ASX - By Stock
|
NSB |
Re:
Ann: NSB - Glaucoma Study Update
|
|
Rippy66
|
59 |
487K |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
59
|
487K
|
2
|
|
ASX - By Stock
|
MEI |
Re:
Ann: Quarterly Activities Report
|
|
Rippy66
|
269 |
153K |
5 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
269
|
153K
|
5
|
|
ASX - By Stock
|
NSB |
Re:
Ann: NSB - Glaucoma Study Update
|
|
Rippy66
|
66 |
54K |
4 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
66
|
54K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
Ann: CVN Model Indicates Neuroprotective Properties of EmtinB
|
|
Rippy66
|
46 |
14K |
7 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
46
|
14K
|
7
|
|
ASX - By Stock
|
NSB |
Re:
Ann: NSB - Company Update
|
|
Rippy66
|
84 |
99K |
1 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
84
|
99K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
NSB Charts
|
|
Rippy66
|
211 |
61K |
5 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
211
|
61K
|
5
|
|
ASX - By Stock
|
NSB |
Re:
NSB Charts
|
|
Rippy66
|
211 |
61K |
5 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
211
|
61K
|
5
|
|
ASX - By Stock
|
NSB |
Re:
alzheimer interview with MD
|
|
Rippy66
|
24 |
6.6K |
0 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
24
|
6.6K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
NSB Charts
|
|
Rippy66
|
211 |
61K |
1 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
211
|
61K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
NSB Charts
|
|
Rippy66
|
211 |
61K |
0 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
211
|
61K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Rippy66
|
22 |
6.8K |
3 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
22
|
6.8K
|
3
|
|